Overview of Dr. Fojo
Dr. Antonio Fojo is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital and NewYork-Presbyterian/Columbia University Irving Medical Center. He received his medical degree from University of Miami Leonard M. Miller School of Medicine and has been in practice 43 years. He is one of 115 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center and one of 368 doctors at New York-Presbyterian Hospital who specialize in Oncology. He has more than 90 publications and over 500 citings.
Office
161 Fort Washington Avenue
Floor 9
New York, NY 10032- Is this information wrong?
Education & Training
- National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1982 - 1985
- Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1978 - 1982
- University of Miami Leonard M. Miller School of MedicineClass of 1977
Certifications & Licensure
- NY State Medical License 2015 - 2025
- MD State Medical License 1983 - 2018
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- LAnreotide in Metastatic Pheochromocytoma / PARAganglioma (LAMPARA) Start of enrollment: 2019 Jun 17
Roles: Sponsor-Investigator, Principal Investigator, Contact
- Entinostat Neuroendocrine (NE) Tumor Start of enrollment: 2017 Dec 23
Roles: Contact, Principal Investigator, Sponsor-Investigator
Publications & Presentations
PubMed
- Analysis of data from the PALOMA-3 trial confirms the efficacy of palbociclib and offers alternatives for novel assessment of clinical trials.Celine Yeh, Mengxi Zhou, Neil Bapodra, Dawn Hershman, Edward Espinal, Marina Moran, Maria Rivero, Antonio Tito Fojo, Susan E Bates> ;Breast Cancer Research and Treatment. 2024 Feb 1
- 4 citationsPARP inhibitors: A review of the pharmacology, pharmacokinetics, and pharmacogenetics.Yi Zeng, Oluwatobi Arisa, Cody J Peer, William D Figg, Antonio Fojo> ;Seminars in Oncology. 2023 Oct 14
- Adjuvant Capecitabine for Biliary Cancer and the Importance of Looking Beyond P-Values.Antonio Tito Fojo, Alfred I Neugut> ;The Oncologist. 2024 Feb 2
- Join now to see all
Hospital Affiliations
- New York-Presbyterian HospitalNew York, New York
- NewYork-Presbyterian/Columbia University Irving Medical CenterNew York, New York
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: